Skip to content

Acupuncture in the Complementary Treatment of Diabetes Mellitus Type II

Acupuncture in the Complementary Treatment of Diabetes Mellitus Type II

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5vrgch
Enrollment
Unknown
Registered
2016-09-22
Start date
2014-10-03
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus

Interventions

Experimental group: 21 participants of both sexes participate in six acupuncture sessions with laser, with weekly intervals. They will be instructed to maintain a fast 2 hours before the scheduled tim
Other
H02.004

Sponsors

Universidade Federal do Rio de Janeiro
Lead Sponsor
Secretaria Municipal de Saúde Vitória / ES
Collaborator
Secretaria Municipal de Saúde de Maricá/ RJ
Collaborator

Eligibility

Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: be aged between 30-75 years; Be in possession of Diabetes Mellitus Type II only; Be in drug treatment for at least 1 year properly prescribed (to be confirmed with the medication of revenue); Report difficulties in glycemic control, regular saving measures higher than recommended by the Brazilian Society of Diabetes (postprandial up to 180mg / dl).

Exclusion criteria

Exclusion criteria: have any of the lower limb amputee or part thereof (due to the location of the selected acupoints to the treatment protocol); Be insulin ; Being a smoker;Be alcoholic; Be in drug treatment for other diseases including obesity ; Be making specific diet for weight loss; Practicing regular physical activity; Be in possession of cancer; Being pregnant

Design outcomes

Primary

MeasureTime frame
Reduction of the postprandial blood glucose.;Longitudinal reduction of blood glucose postprandial. Verification of this reduction will be carried out by comparing the current values with the consultations immediately prior consultations. It is expected that each participant contributes to six values pre and post exposure. Blood glucose will be measured using a glucometer, registered in Imetro. The data will be recorded in an Excel worksheet and the values are compared using the t test for paired measures to a 0.05 significance level. ;It is expected to reduce the values of blood glucose to levels below 180mmdl the participants in the intervention group compared to the placebo group.;The results led to the decrease in blood glucose values to levels below 180mmdl the participants in the intervention group compared to the placebo group.

Secondary

MeasureTime frame
Therapeutic response to nursing diagnoses.;Therapeutic response to nursing diagnoses. The verification of the answers will be held from the comparison of the proportion of nursing diagnoses identified in the first consultation with the proportion of nursing diagnoses identified in the last query. The range of therapeutic response verification scale for complementary and integrative practices will be used to answer the marks obtained in two levels result: improved or not improved. Z test for two proportions will be used to identify statistically significant differences at a 0.05 level.;Expected to observe the resolution of nursing diagnoses identified as problems in participating in the intervention group compared to the placebo group.;The nursing diagnoses showed improvement in the participants in the intervention group compared to the placebo group.

Countries

Brazil

Contacts

Public ContactClaudia ;Neide Aparecida Pereira;Alvim

Universidade Federal do Rio de Janeiro;Universidade Federal do Rio de Janeiro

cdayube@hotmail.com;titonelli@globo.com+55(21)22938999;+55(21)22938999

Outcome results

None listed

Source: REBEC (via WHO ICTRP)